Marengo Therapeutics' CEO Zhen Su on the expansion of a partnership with Ipsen to activate T-cells against cold tumors
After announcing a partnership expansion with Ipsen on Friday, Zhen Su describes how to succeed against cold tumors where T-cells are not in abundance to begin with, you have to activate and then drive them to the tumor.